The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...

The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in ...

The FDA approval covers two treatment algorithms that run on a device made by Medtronic, a medical device company. Both work ...

Bonus Aug 03, 2007 Aug 06, 2007 Apr 30, 2007 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Aug 06, 2004 Aug 09, 2004 Apr 24, 2004 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Sep 17, ...